MAGNET: A Mutation-Aware SE(3) - Equivariant Graph Framework for 3D Binding in KRAS Variants
CSEF · 2026 Medicine & Physiology (Track 2) (Senior Division)
Overview
Annually, 20 million people are diagnosed with cancer, contributing to over 9.7 million deaths. Nearly 25% of these cases are linked to mutations in the KRAS gene, which normally functions as a molecular switch regulating cell growth and apoptosis. Oncogenic mutations hinder KRAS’s ability to hydrolyze GTP to GDP, leading to persistent activation of downstream pathways resulting in cancer-causing tumors. Current in-vitro methods are resource-intensive and slow, while computational models are unable to accurately represent structurally distinct KRAS mutations. Thus, this project introduces MAGNET, a mutation-aware computational framework for precise representation of distinct KRAS mutations. The model integrates three main layers: a FiLM conditioning layer to encode mutation-specific effects, an equivariant message passing layer to preserve structural differences, and a graph transformer layer for a global context. After extensive testing, MAGNET demonstrated excellent predictive performance across main metrics (MAE: 0.0301±0.002, MSE: 0.0026±0.00003, RMSE: 0.051±0.0004, MedAE: 0.007±0.002). Predicted ligands were further validated through Molecular Docking and molecular dynamics simulations, with top ligands reaching -10.1kcal/mol and -7.2kcal/mol, RMSD values < 1.5Å and RMSF values consistently < 1Å and 1.5Å for G12D and G12V respectively. Ultimately, this proves mutation-conditioned equivariant modeling is a powerful tool for accurate representations of structurally distinct mutations. MAGNET provides the first scalable, non-invasive mutation-aware framework for precise modeling of structurally distinct KRAS mutations, offering researchers a powerful tool to accelerate precision oncology and targeted drug discovery.
Competition history
- CSEF 2026
Related projects
CSEF · 2026
Novel Therapeutic Candidates for Rare Cancer (MPNST) via Targeting the Galectin-1/Ras Pathway Using AI-Guided Drug Desig
JSHS · 2024
Grand Theft Transcription Factor: Reversing Tumor Cell Immortality by Transcription Factor Relocalization
CSEF · 2026
Computational Modeling of CXCR4 Receptor–Targeted CAR T-Cells for Medulloblastoma Therapy
CSEF · 2026
Illuminating the Dark Proteome: Integrating Machine Learning to Uncover Relevant Yet Understudied Cancer Targets
ISEF · 2026
Next Generation Cancer Therapeutics: Peptide Binder Impairing Oncogenic KRAS Signalling by Inhibition of KRAS–PDEd Interaction
CSEF · 2026
Copiloting Predictability with AI and ML to Beat the Second Hit in Colorectal, Breast and Lung Cancers
CSEF · 2017
Designing an Innovative Multi-Faceted Smart Drug for Lung Cancer: Revolutionizing Targeted Cancer Treatment
ISEF · 2018
A Novel Computational Solution to Advance Ferromagnetic NanoTherapy to Cure Cancer
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects